Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
European Journal of Endocrinology
|
June 1, 2000
LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer
G Emons, S Weiss, O Ortmann, et al.
European Journal of Endocrinology
|
April 27, 1999
Interactions of ovarian steroids with pituitary adenylate cyclase-activating polypeptide and GnRH in anterior pituitary cells
O Ortmann, W Asmus, K Diedrich, et al.
Archiv Fur Gynakologie
|
January 1, 1975
Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy
H J Künzig, W Geiger, K D Schulz, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 1, 1995
Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and alpha T3-1 gonadotrophs
O Ortmann, M Bakhit, P Bloh, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor
R Hackenberg, T Hawighorst, A Filmer, et al.
Anticancer Research
|
June 6, 1998
Expression of placental protein 14 by the new endometrial cancer cell line MFE-280 in vitro and by endometrial carcinomas in vivo
R Hackenberg, S Loos, A H Nia, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
September 16, 2004
[Differential diagnosis of Poland-syndrome versus unilateral accentuated thelarche]
K Bock, P Hadji, K-D Schulz, et al.
European Journal of Endocrinology
|
November 1, 1996
Modulatory actions of progesterone on gonadotropin-releasing hormone-induced arachidonic acid liberation from perifused rat pituitary cells
O Ortmann, B Ansari-Pirsarai, P Bloh, et al.
The International Journal of Biological Markers
|
September 1, 1987
CA 15.3 as a tumour marker in breast cancer
P Schmidt-Rhode, K D Schulz, G Sturm, et al.
Cancer Research
|
October 15, 1991
Androgen sensitivity of the new human breast cancer cell line MFM-223
R Hackenberg, S Lüttchens, J Hofmann, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
European Journal of Endocrinology
|
June 1, 2000
LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer
G Emons, S Weiss, O Ortmann, et al.
European Journal of Endocrinology
|
April 27, 1999
Interactions of ovarian steroids with pituitary adenylate cyclase-activating polypeptide and GnRH in anterior pituitary cells
O Ortmann, W Asmus, K Diedrich, et al.
Archiv Fur Gynakologie
|
January 1, 1975
Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy
H J Künzig, W Geiger, K D Schulz, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 1, 1995
Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and alpha T3-1 gonadotrophs
O Ortmann, M Bakhit, P Bloh, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor
R Hackenberg, T Hawighorst, A Filmer, et al.
Anticancer Research
|
June 6, 1998
Expression of placental protein 14 by the new endometrial cancer cell line MFE-280 in vitro and by endometrial carcinomas in vivo
R Hackenberg, S Loos, A H Nia, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
September 16, 2004
[Differential diagnosis of Poland-syndrome versus unilateral accentuated thelarche]
K Bock, P Hadji, K-D Schulz, et al.
European Journal of Endocrinology
|
November 1, 1996
Modulatory actions of progesterone on gonadotropin-releasing hormone-induced arachidonic acid liberation from perifused rat pituitary cells
O Ortmann, B Ansari-Pirsarai, P Bloh, et al.
The International Journal of Biological Markers
|
September 1, 1987
CA 15.3 as a tumour marker in breast cancer
P Schmidt-Rhode, K D Schulz, G Sturm, et al.
Cancer Research
|
October 15, 1991
Androgen sensitivity of the new human breast cancer cell line MFM-223
R Hackenberg, S Lüttchens, J Hofmann, et al.
Page
of 8